Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Associations between Polygenic Risk for Psychiatric Disorders and Substance Involvement
Caitlin E. Carey, Arpana Agrawal, Kathleen K. Bucholz, et al.
Frontiers in Genetics (2016) Vol. 7
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

US Epidemiology of Cannabis Use and Associated Problems
Deborah S. Hasin
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 195-212
Open Access | Times Cited: 517
The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities
Stephen V. Faraone
Neuroscience & Biobehavioral Reviews (2018) Vol. 87, pp. 255-270
Open Access | Times Cited: 508
Associations Between Prenatal Cannabis Exposure and Childhood Outcomes
Sarah E. Paul, Alexander S. Hatoum, Jeremy D. Fine, et al.
JAMA Psychiatry (2020) Vol. 78, Iss. 1, pp. 64-64
Open Access | Times Cited: 242
The link between schizophrenia and substance use disorder: A unifying hypothesis
Jibran Y. Khokhar, Lucas L. Dwiel, Angela M. Henricks, et al.
Schizophrenia Research (2017) Vol. 194, pp. 78-85
Open Access | Times Cited: 231
Evidence for the Risks and Consequences of Adolescent Cannabis Exposure
Amir Levine, Kelly Clemenza, Moira A. Rynn, et al.
Journal of the American Academy of Child & Adolescent Psychiatry (2016) Vol. 56, Iss. 3, pp. 214-225
Closed Access | Times Cited: 203
Cannabis and mental illness: a review
Darby J. E. Lowe, Julia Sasiadek, Alexandria S. Coles, et al.
European Archives of Psychiatry and Clinical Neuroscience (2018) Vol. 269, Iss. 1, pp. 107-120
Open Access | Times Cited: 203
Polygenic Risk Scores in Clinical Psychology: Bridging Genomic Risk to Individual Differences
Ryan Bogdan, David A. A. Baranger, Arpana Agrawal
Annual Review of Clinical Psychology (2018) Vol. 14, Iss. 1, pp. 119-157
Open Access | Times Cited: 157
Genome-wide association study implicates CHRNA2 in cannabis use disorder
Ditte Demontis, Veera M. Rajagopal, Thorgeir E. Thorgeirsson, et al.
Nature Neuroscience (2019) Vol. 22, Iss. 7, pp. 1066-1074
Open Access | Times Cited: 125
Comorbidity between ADHD and anxiety disorders across the lifespan
Elisa D’Agati, Paolo Curatolo, Luigi Mazzone
International Journal of Psychiatry in Clinical Practice (2019) Vol. 23, Iss. 4, pp. 238-244
Closed Access | Times Cited: 114
Association of Polygenic Risk for Attention-Deficit/Hyperactivity Disorder With Co-occurring Traits and Disorders
Ebba Du Rietz, Jonathan R. I. Coleman, Kylie P. Glanville, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2017) Vol. 3, Iss. 7, pp. 635-643
Open Access | Times Cited: 101
Consequences of Perinatal Cannabis Exposure
Andrew F. Scheyer, Miriam Melis, Viviana Trezza, et al.
Trends in Neurosciences (2019) Vol. 42, Iss. 12, pp. 871-884
Open Access | Times Cited: 93
Polygenic Scores for Major Depressive Disorder and Risk of Alcohol Dependence
Allan M. Andersen, Robert H. Pietrzak, Henry R. Kranzler, et al.
JAMA Psychiatry (2017) Vol. 74, Iss. 11, pp. 1153-1153
Open Access | Times Cited: 87
Potential use of clinical polygenic risk scores in psychiatry – ethical implications and communicating high polygenic risk
Andrea C. Palk, Shareefa Dalvie, Jantina de Vries, et al.
Philosophy Ethics and Humanities in Medicine (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 84
The addiction risk factor: A unitary genetic vulnerability characterizes substance use disorders and their associations with common correlates
Alexander S. Hatoum, Emma C. Johnson, Sarah M. C. Colbert, et al.
Neuropsychopharmacology (2021) Vol. 47, Iss. 10, pp. 1739-1745
Open Access | Times Cited: 83
Smoking in schizophrenia
Marina Šagud, Alma Mihaljević Peleš, Nela Pivac
Current Opinion in Psychiatry (2019) Vol. 32, Iss. 5, pp. 402-408
Open Access | Times Cited: 74
Association Between Substance Use Disorder and Polygenic Liability to Schizophrenia
Sarah M. Hartz, Amy C. Horton, Mary E. Oehlert, et al.
Biological Psychiatry (2017) Vol. 82, Iss. 10, pp. 709-715
Open Access | Times Cited: 68
Genetics of ADHD: What Should the Clinician Know?
O. Grimm, Thorsten M. Kranz, Andreas Reif
Current Psychiatry Reports (2020) Vol. 22, Iss. 4
Open Access | Times Cited: 68
Genome-wide association meta-analysis of cocaine dependence: Shared genetics with comorbid conditions
Judit Cabana‐Domínguez, Anu Shivalikanjli, Noèlia Fernàndez‐Castillo, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 94, pp. 109667-109667
Open Access | Times Cited: 60
Molecular genetics of cocaine use disorders in humans
Noèlia Fernàndez‐Castillo, Judit Cabana‐Domínguez, Roser Corominas, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 624-639
Open Access | Times Cited: 46
Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence
Lauren Kuhns, Emese Kroon, Karis Colyer‐Patel, et al.
Psychopharmacology (2021) Vol. 239, Iss. 5, pp. 1231-1249
Open Access | Times Cited: 43
Schizophrenia Polygenic Risk and Experiences of Childhood Adversity: A Systematic Review and Meta-analysis
Grace Woolway, Sophie Smart, Amy Lynham, et al.
Schizophrenia Bulletin (2022) Vol. 48, Iss. 5, pp. 967-980
Open Access | Times Cited: 31
Lifetime prevalence and treatment of mental disorders in Saudi youth and adolescents
Yasmin Altwaijri, Alan E. Kazdin, Abdullah Al‐Subaie, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Convergent Evidence for Predispositional Effects of Brain Gray Matter Volume on Alcohol Consumption
David A. A. Baranger, Catherine H. Demers, Nourhan M. Elsayed, et al.
Biological Psychiatry (2019) Vol. 87, Iss. 7, pp. 645-655
Open Access | Times Cited: 49
Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016
Carsten Hjorthøj, Maria Oku Larsen, Marie Starzer, et al.
Psychological Medicine (2019) Vol. 51, Iss. 4, pp. 617-622
Closed Access | Times Cited: 45
A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019
Sebastian Jugl, Aimalohi Okpeku, Brianna Costales, et al.
Medical Cannabis and Cannabinoids (2021) Vol. 4, Iss. 1, pp. 21-42
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top